Identify the BPH patient subpopulation that would benefit most from finasteride/dutasteride therapy.

CLINICAL COURSE
After your recommendations were implemented, Mr McCracken’s BP increased to 130/80 mm Hg, and the BPH and ED symptoms improved remarkably.
Over the ensuing weeks, he continued to experience occasional urgency and hesitancy. After 6 months of watchful waiting, he opted for laser
prostatectomy. This procedure was successful in alleviating his symptoms.
SELF­STUDY ASSIGNMENTS
1 . Compare the efficacy of saw palmetto (Serenoa repens) to finasteride and α1­antagonists for the treatment of BPH.
2 . Compare treatment options for ED in patients with BPH. Identify the risks and potential benefits of using α1­antagonists and 5α­reductase inhibitors
in treating comorbid ED and BPH.
3 . Identify the BPH patient subpopulation that would benefit most from finasteride/dutasteride therapy.
4 . Perform a literature search for evidence that supports use of phosphodiesterase type 5 inhibitors and α1­antagonists as combination therapy for
BPH/ED.
5 . Perform a literature search for the use of phosphodiesterase type 5 inhibitors as monotherapy for LUTS secondary to BPH.